↓ Skip to main content

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial

Overview of attention for article published in Cardiovascular Diabetology, April 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
191 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
Published in
Cardiovascular Diabetology, April 2017
DOI 10.1186/s12933-017-0532-8
Pubmed ID
Authors

Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada, Isao Taguchi, Minako Yamaoka-Tojo, Hirofumi Tomiyama, Hiroki Teragawa, Seigo Sugiyama, Hisako Yoshida, Yasunori Sato, Atsushi Kawaguchi, Yumi Ikehara, Noritaka Machii, Tatsuya Maruhashi, Kosuke R. Shima, Toshinari Takamura, Yasushi Matsuzawa, Kazuo Kimura, Masashi Sakuma, Jun-ichi Oyama, Teruo Inoue, Yukihito Higashi, Shinichiro Ueda, Koichi Node, On Behalf of the EMBLEM Trial Investigators

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 191 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 191 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 30 16%
Student > Master 20 10%
Researcher 19 10%
Other 16 8%
Student > Ph. D. Student 10 5%
Other 32 17%
Unknown 64 34%
Readers by discipline Count As %
Medicine and Dentistry 73 38%
Nursing and Health Professions 16 8%
Pharmacology, Toxicology and Pharmaceutical Science 11 6%
Biochemistry, Genetics and Molecular Biology 7 4%
Agricultural and Biological Sciences 4 2%
Other 10 5%
Unknown 70 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2019.
All research outputs
#7,642,184
of 23,270,775 outputs
Outputs from Cardiovascular Diabetology
#530
of 1,423 outputs
Outputs of similar age
#121,277
of 310,675 outputs
Outputs of similar age from Cardiovascular Diabetology
#12
of 28 outputs
Altmetric has tracked 23,270,775 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,423 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,675 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.